JP Patent

JP2015524394A — ペプチドエポキシケトンプロテアーゼ阻害剤のプロドラッグ

Assigned to Onyx Therapeutics Inc · Expires 2015-08-24 · 11y expired

What this patent protects

本開示は、エポキシケトンプロテアーゼ阻害剤阻害剤のプロドラッグとして有用な化合物を特色とする。【選択図】なし

USPTO Abstract

本開示は、エポキシケトンプロテアーゼ阻害剤阻害剤のプロドラッグとして有用な化合物を特色とする。【選択図】なし

Drugs covered by this patent

ixazomib-citrate (IXAZOMIB CITRATE)

Patent Metadata

Patent number: JP2015524394A
Jurisdiction: JP
Classification: —
Expires: 2015-08-24
Drug substance claim: No
Drug product claim: No
Assignee: Onyx Therapeutics Inc
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.